Uncategorized

Provider Alert!
23Apr

Provider Alert! Updates to the EVV Visit Maintenance Processes Hold for HHAeXchange System Users for Dates of Service Prior to Go-Live Date

Date: April 23, 2024 Attention: STAR Kids Providers/Consumer Directed Services employers, and FMSA Providers Effective Date: April 22, 2024 Call to action: Effective April 22, Electronic Visit Verification (EVV) program providers, financial management services agencies (FMSAs), and Consumer Direct Services (CDS) employers who use HHAeXchange as their EVV system may now perform visit maintenance processes for dates of service prior to their go-live date with HHAeXchange. For Proprietary System Operators (PSOs), the visit maintenance hold for dates of service prior to go-live with their...

By Uncategorized, , , , 0 CommentsRead more...
Provider Alert!
29Feb

Provider Alert! Infant Well-Child Visit Reminder

Date: February 28, 2024 Attention: Primary Care Providers Call to action: Texas Children’s Health Plan (TCHP) encourages providers to ensure their infant patients are receiving timely well-child visits and immunizations, in compliance with the Texas Health Steps (THSteps) periodicity schedule. More specifically, visits must be scheduled on or before the patient’s birth month in order for them to be considered compliant with Health and Human Services (HHSC) THSteps requirements.  TCHP is committed to ensuring members recognize the importance of preventive care and...

By Uncategorized, 0 CommentsRead more...
Provider Alert!
26Feb

Provider Alert! Updates to Vaccine Administration Procedure Code M0201

Date: February 26, 2024 Attention: All Providers Effective: January 1, 2024 Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that effective January 1, 2024, vaccine administration add-on procedure code M0201 may be billed in the home setting with the following procedure codes: 906309063690654906559065690657906589066090661906629067090671906729067390674906779068290685906869068790688906949069790723907329073990740907439074490746907479075690759   M0201 will be payable as an add-on code if billed with any of these vaccines, along with the existing COVID-19 vaccine administration procedure code, if administered inside a client’s home. TCHP will reprocess affected claims submitted with the...

By Uncategorized, 0 CommentsRead more...
Provider Alert!
05Dec

Provider Alert! Synagis (palivizumab) Clinical Prior Authorization Forms Updated with Revised Abrysvo Criteria

Date: December 4, 2023 Attention: All Providers Effective date: November 17, 2023 Call to action: On November 17, 2023, Health and Human Services Commission (HHSC) updated the Synagis Standard Prior Authorization Request (HHS Form 1321) to include a step to check for Abrysvo vaccine administration to the client’s mother during 32 to 36 weeks of pregnancy. How this impacts providers: Additional information on Abrysvo Vaccine include the following: Abrysvo is indicated for active immunization of pregnant individuals at 32 through 36 weeks gestational age for...

By OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, Uncategorized, , , 0 CommentsRead more...
03Nov

Provider Alert! 2023 COVID-19 Vaccine Currently Not Covered on Texas Medicaid and CHIP Formulary

Date: November 3, 2023 Attention: All Providers Call to action:  As of November 1, 2023, COVID vaccines are currently unavailable on the Medicaid and CHIP Formulary at this time. Texas Health and Human Services Commission (HHSC) is working on ways to add the COVID-19 vaccines to the pharmacy benefit. Texas Children’s Health Plan (TCHP) will provide more information as it becomes available.  Next steps for providers:   In the meantime, should your patient inquire about the COVID-19 vaccine, please encourage your patients to receive their...

By OB/GYNs, Office Managers, Primary Care Providers, Provider Alert, Specialists, Uncategorized, , , , , 0 CommentsRead more...
Provider Alert!
27Sep

Provider Alert! Clinical Criteria for Leqembi® (procedure code J0174) effective November 1, 2023

Date: September 26, 2023 Attention: Physicians Effective date for prior authorization criteria: November 1, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective November 1 2023, the Texas Health and Human Services (HHSC) will be implementing prior authorization criteria for Leqembi® (procedure code J0174) for fee-for-service Medicaid. Leqembi (Lecanemab-irmb) is an amyloid-beta directed antibody indicated for early stages of Alzheimer’s disease. Prior Authorization Requirements: Criteria for Initial Approval: Patient has Alzheimer’s disease (Diagnosis codes: G30.0, G30.1, G30.8 or...

By Uncategorized, , 0 CommentsRead more...
Provider Alert!
26Sep

Provider Alert! EVV Users Must Complete Visit Maintenance Before They Lose Access on December 22, 2023

Date: September 25, 2023 Attention: STAR Kids Providers/Consumer Directed Services employers, and FMSA Providers Background information: As a reminder, HHAeXchange will go-live for current EVV users that have not on boarded as a proprietary system operator on October. 1, 2023. Call to action: The purpose of this communication is to inform program providers, financial management services agencies (FMSAs) and Consumer Directed Services (CDS) employers transitioning to the new state EVV vendor, HHAeXchange, are responsible for completing all required visit maintenance (including visit maintenance...

By Uncategorized, , , 0 CommentsRead more...
25Sep

Provider Alert! HHSC Does Not Cover Vaccines or Drugs That Do Not Have FDA Approval or Emergency Use Authorization

Date: September 25, 2023 Attention: All Providers Effective date: August 31, 2023 Call to action: The purpose of this communication is to inform providers that Texas Medicaid and CHIP do not cover vaccines or drugs that are not authorized or approved by the U.S. Food and Drug Administration (FDA). Health and Human Services Commission (HHSC) will not cover procedure codes related to COVID-19 vaccine or drugs administration as non-risk payments (NRP) if the COVID-19 vaccines or drugs no longer have FDA approval or authorization....

By Uncategorized, , , , , 0 CommentsRead more...
Provider Alert!
28Aug

Provider Alert! Non-Risk Based Status for Zynteglo Began July 1, 2023

Date: August 28, 2023 Attention: Physicians Effective Date: July 1, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to let you know that effective July 1, 2023, reimbursement for Zynteglo is non-risk. Zynteglo (procedure code J3590) is a gene therapy for treating adult and pediatric clients with beta-thalassemia requiring regular blood cell (RBC) transfusions. How this impacts providers: Zynteglo is administered in a qualifying treatment center (QTC) for clients that meet prior authorization criteria. QTC is required to send the prescription to...

By Uncategorized, , 0 CommentsRead more...
Provider Alert!
28Jun

Provider Alert! UPDATED: New EVV Vendor System HHAeXchange Launching October 1, 2023

Date: June 28, 2023 Attention: All Providers Effective Date: October 1, 2023 Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that a new single state funded Electronic Visit Verification (EVV) vendor system, HHAeXchange, is launching October 1, 2023. On April 26, 2022, the Texas Health and Human Services Commission (HHSC) posted a solicitation for EVV System Management Services. Through a competitive selection process, HHSC has selected Accenture State Healthcare Services LLC. How this impacts providers: Accenture will continue to...

By Uncategorized, 0 CommentsRead more...